Advisor Group Holdings, Inc. Albireo Pharma, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.0 - $44.95 $0 - $43,691	-972 Closed	0 $0
Q4 2022 Feb 10, 2023	BUY	$18.01 - $23.78 $2,647 - $3,495	147 Added 17.82%	972 $21,000
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $65 - $105	4 Added 0.49%	825 $16,000
Q2 2022 Aug 10, 2022	SELL	$18.54 - $37.29 $13,849 - $27,855	-747 Reduced 47.64%	821 $16,000
Q1 2022 May 04, 2022	SELL	$23.94 - $33.74 $14,747 - $20,783	-616 Reduced 28.21%	1,568 $46,000

Q3 2021 Nov 05, 2021	BUY	$27.36 - $35.98 $57,100 - $75,090	2,087 Added 2151.55%	2,184 $68,000
Q2 2021 Aug 02, 2021	BUY	$28.9 - $36.87 $317 - $405	11 Added 12.79%	97 $4,000
Q1 2021 May 13, 2021	BUY	$32.03 - $42.85 $1,185 - $1,585	37 Added 75.51%	86 $3,000
Q4 2020 Feb 10, 2021	BUY	$31.56 - $42.16 $1,546 - $2,065	49 New	49 $2,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.